ArticleMolecular psychiatry2026
Genetic and functional insights into long noncoding RNAs in schizophrenia.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diet, gut microbiota, and the gut-brain axis: mechanistic interactions and therapeutic implications in neuropsychiatric disorders.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long noncoding RNAs (lncRNAs) are widely expressed regulatory RNAs that play critical roles in diverse biological processes, including brain development, neural stem cell maintenance, and synaptogenesis. Alterations in lncRNA expression have been implicated in schizophrenia (SCZ), however, the genetic drivers and biological consequences of these alterations remain largely unknown. Here, we systematically characterize SCZ associated lncRNAs. We first identify lncRNAs that are significantly dysregulated in the brains of SCZ cases (n = 153) compared with control subjects (n = 300) by using transcriptomic data from the Lieber Institute for Brain Development Phase 2 study (LIBD2). Expression quantitative trait loci (eQTL) analysis uncovers genetic variants that are associated with lncRNA expression in the prenatal and postnatal human brain. By integrating lncRNA eQTL data and genome-wide associations of SCZ, we identify multiple lncRNAs whose genetically regulated expression changes are associated with SCZ. Finally, we selected one candidate lncRNA, LINC01068, for in vitro functional validation, and showed that knockdown of LINC01068 in cultured human neural stem cells (hNSCs) impairs the proliferation, migration, and differentiation of hNSCs. Transcriptomic analysis reveals that LINC01068 regulates SCZ-associated genes and synaptic pathways, indicating the important roles of LINC01068 in SCZ. In summary, this study systematically characterizes SCZ-associated lncRNAs and suggests that LINC01068 confers SCZ risk by affecting neurodevelopment and synaptic-associated pathways. Although our results have not yet been validated in independent datasets, the findings of this study demonstrate the critical roles of lncRNAs and provide important genetic and functional insights into lncRNAs in SCZ.
Indexed as
Identifiers
41392096What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.